Health and Healthcare
730 Articles
Gilead Sciences Inc. (NASDAQ: GILD) is being crushed after a disappointing result in its Hepatitis C treatment after reporting that…
Shortly after Gilead Sciences Inc. (NASDAQ: GILD) announced its $11 billion acquisition of Pharmasett, the company also reported some very…
All three major US stock indexes opened lower this morning and the day was mostly a gentle slide for the…
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this…
Major indexes reacted positively to this morning’s non-farm payrolls report and the drop in the US unemployment rate from 8.5%…
When biotech company Gilead Sciences Inc. (NASDAQ: GILD) made a deal last month to acquire Pharmasett for $11 billion, no…
Earnings season is still upon us. There are going to be many big earnings reports Thursday and we would consider…
Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) has been on fire due to the rapid interest of hepatitis C treatments and the bidding of…
The biotech sector has seen its share of ups and downs in 2011 and prior years. It is almost always…
This last week had some very interesting and influential analyst calls. We compile summaries of many top analyst upgrades, downgrades,…
Reported strong consumer spending over the Thanksgiving holiday weekend pushed stocks up sharply at the opening this morning and gains…
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this morning. Agnico-Eagle Mines…
Gilead Sciences Inc. (NASDAQ: GILD) is trading higher this Monday on a top research upgrade. The biotech was raised to…
These are some of Wednesday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls. Aetna, Inc. (NYSE:…
Stocks opened a bit lower this morning, but almost immediately turned around without being able to break through the opening…
Our top personal finance-related articles today. Your wallet will thank you later.